| Dr Scott Harris Saffold, MD | |
|
36080 Lankford Hwy, Belle Haven, VA 23306-1100 | |
| (757) 442-7040 | |
| (757) 442-7080 |
| Full Name | Dr Scott Harris Saffold |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 30 Years |
| Location | 36080 Lankford Hwy, Belle Haven, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801863162 | NPI | - | NPPES |
| 188364 | Other | MD | MARYLAND PROVIDER NUMBER |
| 236033 | Other | VA | ANTHEM PROVIDER NUMBER |
| 39811 | Other | VA | SENTARA PROVIDER NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverside Shore Memorial Hospital | Onancock, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chesapeake Bay Ent Pc | 4486715018 | 9 |
News Archive
Michael T. Osterholm is Director of the Center for Infectious Disease Research and Policy, Associate Director of the Department of Homeland Security's National Center for Food Protection and Defense, and Professor at the University of Minnesota's School of Public Health.
ChemGenex Pharmaceuticals Limited announced today that updated clinical data from several of its clinical trials with Omapro™ (omacetaxine mepesuccinate) will be presented at the upcoming 51st American Society of Hematology Annual Meeting in New Orleans, Louisiana.
KemPharm, Inc. today announced that it has entered into an exclusive Supply Agreement with Johnson Matthey Inc., for the manufacture of the active pharmaceutical ingredient (API), KP201, KemPharm's novel hydrocodone prodrug for acute pain. KP201 was identified utilizing KemPharm's proprietary ligand activated therapy (LAT) approach.
NuGEN Technologies, a leader in genomics sample preparation, expands the utility of next-generation sequencing for the analysis of microbial species and microbiome samples with its Ovation Prokaryotic RNA-Seq System.
A team led by scientists at The Scripps Research Institute (TSRI) has discovered an unusual bacterial protein that attaches to virtually any antibody and prevents it from binding to its target. Protein M, as it is called, probably helps some bacteria evade the immune response and establish long-term infections.
› Verified 2 days ago
| Entity Name | Chesapeake Bay Ent Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013106541 PECOS PAC ID: 4486715018 Enrollment ID: O20081201000695 |
News Archive
Michael T. Osterholm is Director of the Center for Infectious Disease Research and Policy, Associate Director of the Department of Homeland Security's National Center for Food Protection and Defense, and Professor at the University of Minnesota's School of Public Health.
ChemGenex Pharmaceuticals Limited announced today that updated clinical data from several of its clinical trials with Omapro™ (omacetaxine mepesuccinate) will be presented at the upcoming 51st American Society of Hematology Annual Meeting in New Orleans, Louisiana.
KemPharm, Inc. today announced that it has entered into an exclusive Supply Agreement with Johnson Matthey Inc., for the manufacture of the active pharmaceutical ingredient (API), KP201, KemPharm's novel hydrocodone prodrug for acute pain. KP201 was identified utilizing KemPharm's proprietary ligand activated therapy (LAT) approach.
NuGEN Technologies, a leader in genomics sample preparation, expands the utility of next-generation sequencing for the analysis of microbial species and microbiome samples with its Ovation Prokaryotic RNA-Seq System.
A team led by scientists at The Scripps Research Institute (TSRI) has discovered an unusual bacterial protein that attaches to virtually any antibody and prevents it from binding to its target. Protein M, as it is called, probably helps some bacteria evade the immune response and establish long-term infections.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Scott Harris Saffold, MD 36080 Lankford Hwy, Belle Haven, VA 23306-1100 Ph: (757) 442-7040 | Dr Scott Harris Saffold, MD 36080 Lankford Hwy, Belle Haven, VA 23306-1100 Ph: (757) 442-7040 |
News Archive
Michael T. Osterholm is Director of the Center for Infectious Disease Research and Policy, Associate Director of the Department of Homeland Security's National Center for Food Protection and Defense, and Professor at the University of Minnesota's School of Public Health.
ChemGenex Pharmaceuticals Limited announced today that updated clinical data from several of its clinical trials with Omapro™ (omacetaxine mepesuccinate) will be presented at the upcoming 51st American Society of Hematology Annual Meeting in New Orleans, Louisiana.
KemPharm, Inc. today announced that it has entered into an exclusive Supply Agreement with Johnson Matthey Inc., for the manufacture of the active pharmaceutical ingredient (API), KP201, KemPharm's novel hydrocodone prodrug for acute pain. KP201 was identified utilizing KemPharm's proprietary ligand activated therapy (LAT) approach.
NuGEN Technologies, a leader in genomics sample preparation, expands the utility of next-generation sequencing for the analysis of microbial species and microbiome samples with its Ovation Prokaryotic RNA-Seq System.
A team led by scientists at The Scripps Research Institute (TSRI) has discovered an unusual bacterial protein that attaches to virtually any antibody and prevents it from binding to its target. Protein M, as it is called, probably helps some bacteria evade the immune response and establish long-term infections.
› Verified 2 days ago